4.7 Article

Long non-coding RNA HAGLROS facilitates tumorigenesis and progression in hepatocellular carcinoma by sponging miR-26b-5p to up-regulate karyopherin alpha 2 (KPNA2) and inactivate p53 signaling

Related references

Note: Only part of the references are listed.
Article Medical Laboratory Technology

Long non-coding RNA HAGLROS promotes the development of diffuse large B-cell lymphoma via suppressing miR-100

Ling Shu et al.

Summary: The study revealed that overexpression of HAGLROS in DLBCL is closely associated with advanced clinicopathological features and poor survival outcomes. HAGLROS functions as a competitive endogenous RNA for miR-100 in DLBCL cells, promoting cancer progression. Targeting HAGLROS-miR-100 axis could be a potential prognostic biomarker and therapeutic target for DLBCL patients.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Medicine, Research & Experimental

Interference of long non-coding RNA HAGLROS inhibits the proliferation and promotes the apoptosis of ovarian cancer cells by targeting miR-26b-5p

Lin Zhu et al.

Summary: The study revealed that HAGLROS was highly expressed in ovarian cancer cells, and interference of HAGLROS suppressed proliferation and promoted apoptosis by regulating miR-26b-5p. This suggests that HAGLROS may be a promising biomarker for diagnosis and treatment of ovarian cancer.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Article Biotechnology & Applied Microbiology

LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis

Yanqing Feng et al.

Summary: Accumulating evidence suggests that long noncoding RNA (lncRNA) DARS-AS1 plays a role in hepatocellular carcinoma (HCC) by promoting cell proliferation and migration through upregulating CKAP2. Additionally, DARS-AS1 inhibits miR-3200-5p, leading to activation of CKAP2 and the FAK-ERK pathway in HCC. This study highlights DARS-AS1 as a potential target for HCC diagnosis and treatment.

BIOENGINEERED (2021)

Article Biotechnology & Applied Microbiology

MicroRNA-26b-5p suppresses the proliferation of tongue squamous cell carcinoma via targeting proline rich 11 (PRR11)

Liang Yi et al.

Summary: miR-26b-5p is decreased in TSCC tissues and induces cell cycle arrest by targeting PRR11, suggesting it as a promising therapeutic strategy for TSCC treatment.

BIOENGINEERED (2021)

Article Oncology

International trends in hepatocellular carcinoma incidence, 1978-2012

Jessica L. Petrick et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Medicine, Research & Experimental

The emerging roles of KPNA2 in cancer

Yang Han et al.

LIFE SCIENCES (2020)

Article Mathematical & Computational Biology

Long Noncoding RNA HAGLROS Promotes Cell Invasion and Metastasis by Sponging miR-152 and Upregulating ROCK1 Expression in Osteosarcoma

Kaifeng Zhou et al.

COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2020)

Article Oncology

HAGLROS is overexpressed and promotes non-small cell lung cancer migration and invasion

Ying Chen et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Oncology

Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1

Yu-Gang Wang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Review Oncology

Molecular pattern of lncRNAs in hepatocellular carcinoma

Haoming Mai et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Obstetrics & Gynecology

Clinical significance and oncogene function of long noncoding RNA HAGLROS overexpression in ovarian cancer

Meiqin Yang et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2019)

Article Public, Environmental & Occupational Health

The Changing Epidemiology of Primary Liver Cancer

Jessica L. Petrick et al.

CURRENT EPIDEMIOLOGY REPORTS (2019)

Review Gastroenterology & Hepatology

Hepatocellular Carcinoma: Etiology and Current and Future Drugs

Aastha Jindal et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)

Article Biochemistry & Molecular Biology

Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types

Xinggang Guo et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2019)

Review Oncology

Targetable long non-coding RNAs in cancer treatments

Liang Chen et al.

CANCER LETTERS (2018)

Review Oncology

Emerging roles of long non-coding RNA in cancer

Anna Sanchez Calle et al.

CANCER SCIENCE (2018)

Review Cell Biology

Cytoplasmic functions of long noncoding RNAs

Ji Heon Noh et al.

WILEY INTERDISCIPLINARY REVIEWS-RNA (2018)

Review Biochemistry & Molecular Biology

Long non-coding RNA: Functional agent for disease traits

Sriyans Jain et al.

RNA BIOLOGY (2017)

Review Gastroenterology & Hepatology

Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets

Marcel Klingenberg et al.

JOURNAL OF HEPATOLOGY (2017)

Review Biochemistry & Molecular Biology

Perspectives of long non-coding RNAs in cancer

Arunagiri Kuha Deva Magendhra Rao et al.

MOLECULAR BIOLOGY REPORTS (2017)

Review Oncology

Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology)

Aysegul Ozakyol

JOURNAL OF GASTROINTESTINAL CANCER (2017)

Review Oncology

The functional role of the novel biomarker karyopherin α 2 (KPNA2) in cancer

Anders Christiansen et al.

CANCER LETTERS (2013)

Article Gastroenterology & Hepatology

Epidemiology of Hepatocellular Carcinoma Consider the Population

Sahil Mittal et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)